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Sulnnlary 
The relationship between activation-induced growth inhibition and regulation of the cell cycle 
progression  was  investigated  in  T  cell  hybridomas by  studying  the  function  of the  cell 
cycle-regulating genes such as G1 cyclins and their associated kinases. Activation ofT cell hybrid- 
omas by anti-T cell receptor antibody induces growth arrest  at G1 phase of the cell cycle and 
subsequently results in activation-driven cell death. Rapid reduction of both messenger RNA 
and protein level of the cyclin D3 is accompanied by growth arrest upon activation.  Although 
the residual cyclin D3 protein forms a complex with cdk4 protein, cyclin D3-dependent kinase 
activity is severely impaired. Stable transfectants engineered to express cyclin D3 override the 
growth arrest  upon activation.  These results imply that the activation signal through T  cell 
receptor induces the down-regulation of cyclin D3 expression and cyclin D3-dependent kinase 
activity,  leading to growth arrest  in G1 phase of the cell cycle in T  cells. 
M 
ature T lymphocytes in peripheral tissues start to pro- 
. liferate in response to antigen stimulation. However, 
the same  stimulation through the TCR complex induces 
growth arrest and activation-driven cell death (ADCD) 1 in 
T cell hybridomas or tumor cells (1). Moreover, growth in- 
hibition and ADCD have been found to be induced even in 
normal T ceils and T cell clones if they are reactivated through 
TCR when ceils are proliferating in the presence of IL-2 (2-4). 
These observations raise the hypothesis that the activation 
signal through the TCK complex modifies cell cycle regula- 
tion and results in cell cycle arrest  and ADCD in prolifer- 
ating T  cells. 
D-type cyclins, cyclin E, and cdk's are important regulators 
of cell progression from G1 to S phase and of initiation of 
DNA synthesis (5-9).  When quiescent cells are stimulated 
to initiate proliferation by the addition of growth factor, both 
D-type cyclins and cyclin E are induced (9-14).  Generally, 
D-type cyclins are induced earlier than cyclin E in G1 phase 
(15-18).  It has been shown that cyclin E associates mainly 
with cdk2, whereas the major partners of D-type cyclins are 
cdk4 and the recently identified kinase, cdk6 (15-21).  The 
constitutive expression of cyclin E as well as of D-type cy- 
dins suppresses the growth-inhibitory activity ofretinoblas- 
toma protein (pRb) in a pRb-deficient osteosarcoma cell line 
(22-24). In addition, the enforced expression of cyclin E and 
D-type cyclins has been shown to shorten the duration of 
G1 phase, and microinjection of cyclin D1 antisense DNA 
or of antibodies specific for cyclin D1 during G1 phase in- 
hibits cells from exiting to S phase (25,  26). 
The role of cyclin E and D-type cyclins and their associated 
cdk kinases in inhibiting the G1 phase progression was also 
studied. TGF-3 induces G1 arrest by down-regulation of cdk4 
kinase, and it activates p27 and p15, the inhibitors for cdk's 
(27-33). Growth arrest at G1 phase by radiation-induced DNA 
damage is due to another inhibitor of cyclin E-cdk complex, 
p21 (34-37). Cell cycle arrest at G1 phase appears to be regu- 
lated mainly by these inhibitors in these systems. Whether 
this mechanism is important in lymphocytes is yet unknown. 
We took advantage of the unique situation of T cell hy- 
bridomas, namely, that the activation signal through the TCR 
complex induces cell cycle arrest, to understand the function 
of G1 cyclins and cdk's in cell cycle regulation. Here we re- 
port that down-regulation of cyclin D3-associated kinase ac- 
tivity, mainly due to the reduction of cyclin D3 expression, 
is critical for the induction of G1 arrest in T cell hybridomas. 
a Abbreviations used in this paper: ADCD, activation-driven  cell death; DTT, 
dithiothreitol;  GST, glutathione  S-transferase;  mKNA, messenger  KNA; 
PI, propidium  iodide;  pKb, retinoblastoma  protein; TBST, Tris-buffered 
saline with 0.2% Tween 20. 
Materials  and Methods 
Cells and mAbs.  T cell hybridoma DOl1.10 (38) is a chicken 
ovalbumin-specific  T cell hybridoma expressing V38 that can be 
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provided by Dr. P. Marrack (National Jewish Center, Denver, CO). 
Hybridoma  cells  were  cultured  in  RPMI  1640  medium  sup- 
plemented with 10% FCS, 4 mM glutamine, 100/~g/ml kanamycin, 
and 50/~M 2-ME (complete medium) at a density of 1-6  x  10  s 
cells per ml. F23.1 mAb was purified from ascites by ammonium 
sulfate precipitation and protein A-Sepharose column (Pharmacia 
LKB Biotechnology, Inc., Piscataway, NJ). Anti-mouse cyclin D2 
and D3 mAbs were kindly provided by Dr. C. J. Sherr (St. Jude 
Children's Hospital, Memphis, TN). Anti-cdk4 mAb was raised 
against  a synthetic COOH-terminal peptide of mouse cdk4 and 
will be described elsewhere (Kato, A., and H. Matsushime, manu- 
script in preparation). Anti-human cdk2 antiserum was purchased 
from Pharmingen (San Diego, CA). 
T Cell Hybridoma Synchronization.  Cells were synchronized at 
the G1/S phase boundary by the double-thymidine block protocol 
(40). Briefly, DOl1.10 T hybridoma cells were incubated in com- 
plete medium containing 12 mM thymidine for 5 h, washed three 
times,  and incubated for another 5 h without thymidine. Thymi- 
dine was then added again at the same concentration, and the cells 
were incubated for another 5 h. The cell cycle analysis confirmed 
that >75%  of the cells were in G1 phase. 
Cell Cycle Analysis.  3-5  x  106 cells were pelleted, resuspended 
in 0.5 ml of 4-mM sodium citrate containing 0.05% NP-40, 0.45 
mg/ml RNase, and 50/~g/ml propidium iodide (PI), and incubated 
for 10 min on ice. Then 50/zl of 1.5-M NaC1 was added to the 
suspension. The proportions of cells in G1, S, and G2 phases of 
the cell cycle were analyzed by flow cytometry on a FACScan  |  with 
Cellfit software (Becton Dickinson Advanced Cellular Biology, San 
Jose,  CA). 
Activation of T Cell Hybn'doma.  12-well  flat-bottomed plates were 
coated with 1 ml of 20 #g/ml of mAb F23.1 for 12 h at 4~  and 
then washed three times with PBS. 3 ml of I  x  10  s cells per ml 
hybridoma cells was placed on the F23.1-coated plates for activation. 
RNA Blotting.  Total RNA was extracted from hybridoma cells 
as previously described (41), fractionated on 1% agarose-formalde- 
hyde gel, and blotted to membrane (Hybond-N +  ; Amersham In- 
ternational, Little Chalfont, UK) by conventional capillary blot- 
ting. Membranes were hybridized with cDNA probes labeled with 
o~-[32p]dCTP by a DNA labeling kit (Megaprime; Amersham In- 
ternational), washed at a final stringency of  0.5  x  SSC, 0.1% SDS 
at 65~  and analyzed with an image analyzer (BAS2000; Fuji Photo 
Film Corporation, Tokyo,  Japan). The signals were quantitated and 
normalized to the ~/-actin signals. The following probes for var- 
ious G1 cyclins, cdk2, and actin were used: human cyclin C, 2.1-kb 
BgllI-HindlII fragment (6); mouse cyclin D1, 1.1-kb BamHI EcoRI 
fragment excised from plasmid pGEX-3X-CYL1 (9); mouse cyclin 
D2,  1.2-kb EcoRI fragment excised from plasmid pcN9cyl2 (9); 
mouse cyclin D3, 2.2 kb EcoRI fragment excised from plasmid 
pmCyD3;  human cyclin E cDNA,  1.5-kb EcoRI-HindlII frag- 
ment (6); human cdk2 cDNA, I kb HindlII-BamHI fragment (42); 
mouse/3 actin cDNA of 3' untranslated region, 1-kb EcoPd-BamHI 
fragment excised from plasmid pSPM~-'3UT (43). The plasmids 
containing the human cyclin C and E were kindly provided by Dr. 
S. I. Reed (Scripps Research Institute, La Jolla, CA). The plasmids 
pGEX-3X-CYL1 and pcN9cyl2 were generously donated by Dr. 
C. J. Sherr (St. Jude Children's Hospital). The plasmids containing 
cdk2 cDNA were gratefully received from Dr. E. Harlow (Mas- 
sachusetts  General Hospital Cancer Center, Charlestown, MA). 
The mouse cyclin D3 cDNA was cloned from a XZAP cDNA li- 
brary prepared from mouse thymus cDNA (Stratagene,  Inc., La 
Jolla, CA) and screened  with mouse cyclin D3 cDNA obtained 
by PCR. using the synthesized primers from the published amino 
acid sequences (9). The primers used were 5'CAAAGCTTGCNT- 
AYTGGATGYTY and 5'TCGAATTCARKTAKTTCATNGC3'. 
Mouse cyclin E cDNA was cloned from the same library with human 
cyclin E cDNA as a probe. The mouse cyclin E clone was sequenced 
and the homology to the human cyclin E cDNA sequence  was 
confirmed. 
Cell Viability.  For determining the viability of cells, 0.5-1  x 
106 cells were pelleted and resuspended in PBS containing 5% FCS 
and 10 #g/ml PI. The numbers of cells stained with PI (dead cells) 
and  not  stained  with  PI  (live cells)  were determined by flow 
cytometry. 
Immunoprecipitation and Western Blotting.  5  x  106-1 x  107 cells 
were washed twice with PBS and lysed on ice in 1 ml oflysis buffer 
(250 mM NaC1, 0.1% NP-40, 50 mM Hepes, pH 7.0, 5 mM EDTA, 
50 mM NaF, 0.1 mM sodium orthovanadate, 50 #g/ml of PMSF, 
1 #g/ml of leupeptin, 1 #g/ml of aprotinin, and I mM dithiothre- 
itol [DTT]). 1 #1 of anti-mouse cyclin D2 or D3 mAb was used 
for immunoprecipitation as described  by Harlow and Lane (44). 
The proteins were resolved on 12% SDS-PAGE and transferred to 
polyvinyl difluoride membrane (Immobilon-P; MiUipore Corp., Bed- 
ford, MA). Blots were blocked in Blockace (Yukijirnshi,  Sapporo, 
Japan),  washed four times with Tris-buffered  saline with 0.2% 
Tween 20 (TBST), and incubated with first antibodies in TBST 
for 1 h at room temperature. Rabbit anti-human cdk2 and af~nity- 
purified mAbs against cdk4, cyclin D2, and cyclin D3 were all diluted 
1,000-fold.  The blots were then washed four times with TBST, 
incubated with secondary antibodies (af~nity-purified sheep anti- 
mouse, sheep  anti-rat antibody, or donkey anti-rabbit antibody 
conjugated with horseradish peroxidase [Amersham International]) 
at a 1:10,000 dilution, washed four times with TBST, and devel- 
oped with enhanced chemiluminescence reagent (Amersham In- 
ternational). 
Immune Complex Kinase Assay.  Immune complex kinase assay 
was performed as described previously (45).  5  x  106 cells were 
suspended  in IP buffer (50 mM Hepes, pH 7.5, 150 mM NaC1, 
1 mM EDTA, 2.5 mM EGTA, 1 mM DTT, and 0.1% Tween-20) 
containing 10% glycerol, 0.1 mM PMSF, 10/~g/ml of leupeptin, 
20 U/ml of aprotinin, 10 mM fl-glycerophosphate, 1 mM NaF, 
and 0.1 mM sodium orthovanadate, and they were sonicated at 4~ 
The clarified lysates were precipitated with mAbs against mouse 
cyclin D2 or cyclin D3 and rabbit antisera against human cdk2 or 
mouse cdk4. The immune complexes were precipitated for 2 h at 
4~  with protein G-Sepharose beads. Immunoprecipitated proteins 
were washed with IP buffer and suspended in a kinase buffer (50 
mM Hepes, pH 8.0, 10 mM MgCI2,  1 mM DTT) containing 0.2 
/~g of soluble glutathione S-transferase  (GST)-Rb fusion protein 
and  2.5  mM  EGTA,  10 mM  fl-glycerophosphate, 20  U/ml  of 
aprotinin, 0.1  mM PMSF,  1 mM NaF, 0.1  mM sodium ortho- 
vanadate,  20 #M ATP, 2 mM reduced glutathione,  and 10/~Ci 
y-[32p]ATP. After incubation for 20 min at 30~  with occasional 
mixing, the samples were boiled for 5 rain and resolved on 10% 
SDS-PAGE.  GST-Rb was  prepared as described previously (45). 
DNA Transfection.  The expressible construct for mouse cyclin 
D3 was prepared by subcloning of the EcoRI fragment of the mouse 
cyclin D3 into the EcoRI site of the pMKITneo vector containing 
SRcr promoter and neo  r gene (kindly provided by Dr. K. Marn- 
yama, Tokyo Medical and Dental University, Tokyo, Japan). The 
linearized plasmid was transfected into cells by electroporation as 
described previously (46). Briefly, 107 DOl1.10 cells were washed 
thee  times  with  ice-cold  PBS  and  resuspended in  0.8  ml ice- 
cold K-PBS buffer (30.8  mM  NaC1,  120.7  mM KC1, 8.1  mM 
NazHPO4, and 1.46 mM KHzPO4). 30/~g of linearized plasmid 
DNA was added to the cell suspension  in a cuvette (Gene Pulser 
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pulse (310 V, 960/~F)  was applied with a Gene Pulser (Bio-Rad 
Laboratories). Cells were cultured  at 10  s cells per well in 96-well 
plates in the complete medium and selected after 24 h in the pres- 
ence of 1 mg/ml Geneticin  (GIBCO BRL, Gaithersburg,  MD). 
Results 
T Cell Activation Induced Rapid Changes of the Expression 
of G1 Cyclins and Their Associated Kinases before Cell Cycle 
Arrestand CellDeath.  T cell hybridoma DOl1.10 was stimu- 
lated by engaging the TCR complex with immobilized anti- 
TCR-/3 antibody F23.1. Flow cytometric analysis of the cell 
cycle indicated that the activation of T cells induced the cell 
cycle arrest at G1 phase (Fig.  1 A).  The number of cells in 
early S phase started to decrease 4 h after stimulation, whereas 
cells in G1 phase started  to increase.  The reduction of the 
cell number in S phase continued until 8 h after stimulation, 
with the percentage changing  from 60 to 30%  (Fig.  1 A). 
Cell viability was also measured by staining dead cells with 
PI and was analyzed by flow cytometry. Dead cells were first 
observed at 6 h after stimulation, and about half of the popu- 
lation  died after  12 h  (Fig.  1 B). 
To study the role of G1 cyclins and cdk2 kinase in the in- 
duction of the G1 arrest, the expression of these genes after 
activation of T cells through TCR was analyzed. Total RNA 
was isolated from DOl1.10 cells at each time point after stim- 
ulation and analyzed on RNA blots using probes of G1 cy- 
clins and cdk2 as well as B-actin as a control (Fig.  2). Mes- 
senger RNAs (mRNA) of cyclin D2 and C increased gradually 
and reached a maximum level two- to threefold higher than 
the basal level.  Their expression returned to the basal level 
at 12 h (Fig. 2). Importantly, the mR.NA level of cyclins D3, 
E, and cdk2 sharply decreased and reached their lowest level 
within 4 h after stimulation. Thereafter,  while cyclin E mRNA 
recovered rapidly, cyclin D3 recovered partially and cdk2 re- 
mained at a low level (Fig. 2). Cyclin D1 expression was not 
detected in this T cell hybrido'ma (Miyatake, S., and T. Saito, 
unpublished  observation). 
Cyclin D3 Protein Decreased  after Stimulation through TCR. 
To determine whether the protein levels of these genes corre- 
late with the amounts of mR.NAs, cyclin D2, D3, cdk2, and 
cdk4 proteins were immunoprecipitated from the cell lysates 
of synchronized and stimulated DOl1.10 cells and detected 
by immunoblot analysis.  The cell cycle was synchronized by 
double-thymidine block procedure to obtain clear results for 
these proteins  (Fig.  3 A).  At 2 h after release from the G1 
block (time 0 h),  ",90%  of the cells were in mid-S phase, 
and half of the cells were stimulated with  anti-TCR mAb 
and harvested at various times after stimulation.  After 3 h 
(time 3 h),  •35%  of nonstimulated  cells were in S phase, 
whereas 65% of stimulated cells were still in S phase.  After 
6 h (time 6 h), nonstimulated  cells were not left in G2/M 
phase,  whereas  ~10%  of stimulated  cells  were in  G2/M 
phase. Overall, the cell cycle became slower after stimulation 
but, nonetheless, was not arrested until the cells entered G1 
phase (Fig.  3 A). 
The protein level of cyclin D3,  which was found to re- 
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Figure  1.  Cell  cycle  arrest and cell death induced upon T cell activa- 
tion. (.4) Cell cycle  arrest of DOl1.10 hybridomas  upon activation. DOl1.10 
cells were stimulated by immobilized F23.1 mAb, stained with PI at the 
indicated times after stimulation, and subjected to cell cycle  analysis by 
FACScan  |  (B) Kinetics of cell death of DOl1.10 cells upon stimulation. 
The number of PI-stained cells, i.e., dead cells, was determined by FACS  | 
analysis. All results represent the analysis of 104 cells. 
main constant throughout the cell cycle, was reduced to ap- 
proximately one-sixth at both 3 and 6 h after TCR stimula- 
tion (Fig.  3 B). The level of cyclin D2 protein,  which does 
not fluctuate throughout  the cell cycle,  gradually increased 
after stimulation. 
Fig. 3 B also shows that the changes of the protein level 
of both cdk2 and cdk4 were minimal compared with those 
of cyclin D2 and D3 proteins. The cyclin D3-cdk4 complex 
was then analyzed by immunoprecipitation with anti-cyclin 
D3 mAb followed by immunoblot with anti-cdk4 antiserum. 
As shown in Fig. 3 C, the amount of cdk4 protein within 
the complex decreased to the same extent as that  of cyclin 
D3 upon  stimulation,  indicating  that  the complex forma- 
tion of cyclin D3 and cdk4 was not altered by TCR stimula- 
tion,  and the amount of the cyclin D3-cdk4 complex was 
determined by the level  of cyclin D3. 
Stimulation through TCR Inhibits Cyclin D3-associated  Kinase 
Activity.  GST-Rb protein has been reported to be a specific 
substrate for detecting D-type cyclin-associated kinases such 
as cdk4 and cdk6 (15-17, 21). We used this system to analyze 
cyclin D3-associated kinase activity. DOl1.10 cells were syn- 
chronized and stimulated 2 h later when most cells were in Figure 2.  Expression of transcripts of G1 cyclins and 
cdk2 in DOl1.10 hybridoma cells upon TCR stimulation. 
Total RNAs from DOl1.10 cells at the indicated periods 
after stimulation  with immobilized F23.1 mAb were ana- 
lyzed with probes corresponding to cyclin C, cyclin D2, 
cyclin D3 (C), cyclin E, cdk2, and 13-actin  (D). The ra- 
dioactivity of each band was quantitated and normalized 
to that of 13-actin (A, B). 
S phase (time 0 h). Cell lysates were prepared from unstimu- 
lated cells (time 0 h) and stimulated cells 6 h later (time 6 h). 
A significant level of cyclin D3-associated kinase activity was 
detected in nonstimulated cells, which was reduced to <10% 
after TCR  stimulation  (Fig.  4).  Since cyclin D3  decreased 
to one-sixth of the original level, inhibition of cyclin D3-as- 
sociated kinase activity is mostly attributable  to the reduc- 
tion of cyclin D3 expression.  However,  the kinase activity 
was impaired more severely in comparison with the reduc- 
tion of the cyclin D3  level. 
Although cyclin D2 protein was detected in the DOl1.10 
cell line, there was very little cyclin D2-associated kinase ac- 
tivity, cdk2 and cdk4 kinase activities were also measured. 
cdk2 had a significant level of kinase activity, while cdk4 ki- 
nase activity was lower than that of the cyclin D3 complex 
in unstimulated cells.  Both kinase activities were inhibited 
to  ~40%  upon stimulation  (Fig.  4). 
Constitutive  Expression  of Cyclin  D3 Altered T  Cells  to Be 
Resistant to Growth Arrest.  To prove the hypothesis that the 
level of cyclin D3 and D3-associated kinase activity controls 
Figure 3.  Analysis of protein expression of cyclin D2, 
cyclin  D3, cdk2, and cdk4 protein as well as cyclin  D3-cdk4 
complex in synchronized DOl1.10 cells upon TCR stim- 
ulation. (A) Cell cycle analysis of synchronized DOl1.10 
hybridomas. DOl1.10 cells  were synchronized as described 
in Materials and Methods. Cells were stimulated (or not) 
with immobilized  F23.1 mAb 2 h after synchronization. 
At the indicated times, cell cycle analysis as well as pro- 
tein analysis were performed.  (B) Protein level of cyclin 
D2 (a), D3 (b), cdk2 (c), and cdk4 (d) in DOl1.10 cells 
upon TCR stimulation. The lysates were prepared from 
the synchronized and stimulated cells at indicated time 
points as in A. For cyclin D2 and D3, mAbs were used 
for both precipitation  and immunoblots. For cdk2 and 
cdk4,  the lysates were blotted with rabbit anti-human 
cdk2 antiserum and mouse anti-cdk4 mAb. (C) Protein 
analysis of the cyclin D3-cdk4 complex. The same blot 
for cyclin  D3 (lane b in B) was reblotted with anti-mouse 
cdk4 antiserum. 
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Figure  4.  Activity  of cyclin  D2- and cyclin  D3-associated  kinases as 
well as cdk2 and cdk4. Cell lysates  of DOl1.10 cells stimulated  for 8 h 
with F23.1 were  immunoprecipitated  with mAb (cyclin  D2 and D3), an- 
tiserum (cdk2 and cdk4), or without Ab (beads), and the kinase activity 
of the immune complex  was analyzed  using GST-R.b as a substrate. In 
all experiments,  lysates  equivalent  to 1 x  106 cells  were  loaded  per lane. 
The radioactivity  incorporated  in the Rb band of  SDS-PAGE  was quanti- 
tated by an image analyzer. 
the cell cycle progression in T cells, stable transfectants con- 
stitutively expressing cyclin D3 were established. 
Expressible construct of mouse cyclin D3 was prepared in 
a plasmid vector pMKITneo containing SRol promoter and 
introduced into DOl1.10 cells. More than 10 G418-resistant 
clones were isolated,  and the expression of the introduced 
genes was analyzed by Northern blot, immunoblot, and kinase 
assay (Fig. 5, A-C). Two representative clones, DOCyD3-3 
(done 3) and DOCyD3-18 (done 18), were described here. 
We could not obtain any transfectants expressing higher levels 
of mRNA and cyclin D3 protein than the endogenous one 
(Fig.  5, A  and B). While the protein level of cyclin D3 de- 
creased upon stimulation in parental DOLL10 cells, that in 
the two clones was rather enhanced upon stimulation. Con- 
sequently, these stimulated transfectants expressed a higher 
level of cyclin D3 protein than the stimulated parental cell 
line, and this resulted in the enhancement of cyclin D3-as- 
sociated kinase activity in the transfectants (Fig.  5,  B  and 
C). cdk2 kinase activity was also increased in these transfec- 
tants  (Fig,  5  D). 
The cell cycle of the cydin D3 transfectants upon stimula- 
tion was analyzed by flow cytometry (Fig. 5 E). As described 
above, G1 arrest was induced, and the percentage of cells in 
S phase decreased to <30%  within 8 h after stimulation in 
parental DOl1.10 cells. In contrast, cyclin D3 transfectants 
revealed significant recovery  from the arrest. At 8 h after stim- 
ulation, the percentage of cells in S phase only decreased to 
~50%  in the two clones (Fig.  5 E). Furthermore, growth 
inhibition  detected by  [3H]thymidine incorporation  after 
stimulation was significantly suppressed in the transfectants 
(Fig. 5 F). These data strongly suggest that activation-induced 
growth arrest at G1 to S transition was suppressed by the 
ectopic expression of cyclin D3. Doubling time and cell size 
were not affected by the enforced expression of cyclin D3 in 
T  cell hybridoma cells. 
The activation signal upon TCR stimulation induces cell 
cycle arrest at G1 phase but not in other stages of the cell 
cycle of T cell hybridomas, as reported before (1). This was 
dearly demonstrated when the cell cycle of T  cell hybrid- 
omas was synchronized and the cells were stimulated during 
S phase.  T  cells continued the cell cycle until entering G1 
phase, where they stopped its progression. Furthermore, in- 
duction of ADCD was observed after the cell cycle was ar- 
rested at G1 phase, suggesting that ADCD occurs at G1 phase. 
The induction of growth arrest is accompanied by the rapid 
reduction of the mRNA level of three genes: cyclin E, cyclin 
D3, and cdk2. The reduction of cyclin E mRNA was small 
and recovered rapidly. The expression of cdk2 protein was 
minimally changed upon stimulation in spite of the reduc- 
tion of the transcript. By contrast, cyclin D3 protein decreased 
in parallel with mRNA after stimulation. Furthermore, cy- 
din D3-associated kinase activity also  decreased. In cyclin 
D3-expressing transfectants, the expression of cyclin D3 pro- 
tein increased upon stimulation, resulting in the elevated level 
of cyclin D3-associated kinase activity. Subsequently, the trans- 
fectants gained resistance to the induction of G1 arrest upon 
TCR stimulation.  Together, these results indicate that the 
cyclin D3-associated kinase activity is controlled by the ex- 
pression level of cyclin D3, that this regulation seems to be 
critical for T  cells to proceed from G1 to S phase, and that 
TCtk  stimulation  induces  growth  inhibition  by  down- 
regulating the expression of cyclin D3  protein. 
One of the mechanisms of TGF-3 to induce G1 arrest in 
epithelial cells is the down-regulation of cdk4 rather than 
D-type cyclins (28). Therefore, the target of the antiprolifer- 
ative signal induced through TCR is different from that of 
TGF-~. The other mechanism of TGF-3-induced G1 arrest 
is the activation of inhibitors for the kinase activity of cdk's 
(27-33). The inhibitor activity was demonstrated when the 
cell lysate of TGF-B-treated cells was mixed with  that  of 
proliferating cells.  In our system, the cydin D3-associated 
kinase activity was more severely impaired upon stimulation 
as compared with the reduction of the cydin D3 protein, 
suggesting that additional mechanisms may operate to sup- 
press  the kinase activity. In cyclin D3 transfectants, the cy- 
din D3  protein level was increased upon stimulation, but 
the kinase activity in these transfectants was still slightly re- 
duced, and weak inhibition of the cell cycle progression was 
observed. Taken together, these results indicate that cyclin 
D3-associated kinase activity is inhibited not only by the reduc- 
tion of cyclin D3 protein but also by additional mechanisms 
such as the suppression by inhibitors.  We analyzed the ex- 
pression of mouse p21  (Cipl/WAF1/Sdil)  and p27  (Kip1) 
on RNA blots.  A  low level of p21  mRNA was detected, 
and it was slightly decreased upon stimulation. On the other 
hand, the p27 mRNA was increased by threefold upon stim- 
ulation through TCR  (Miyatake, S.,  and T.  Saito,  unpub- 
lished observation), suggesting that p27 may contribute to 
the inhibition of cyclin D3-associated kinase activity in T 
cell hybridoma DOl1.10. 
The kinase activity of cdk4,  a major partner of D-type 
405  Miyatake  et al. Figure  5.  Effects  of constitutive expression of cyclin D3 on the activation-induced  cell cycle arrest in T cell hybridomas. (-4) Expression of cyclin 
D3 mKNA in DOl1.10 and cyclin D3 transfectants (DOCyD3-3  and -18). (B) Protein level of cyclin D3 in stimulated or unstimulated DO11.10 
cells and cyclin D3 transfectants. (C) Activity of cyclin  D3-associated kinase in stimulated or unstimulated DOl1.10 cells and cyclin  D3 transfectants. 
(D) Activity of cdk2 in stimulated or unstimulated DOl1.10 cells and cyclin D3-transfectants. Results of cdk2 kinase activity were quantitated with 
an image analyzer and plotted relative to the amount of kinase activity recovered  from immunoprecipitates  from unstimulated parental DOl1.10 cells. 
(E) Cell cycle  analysis  of  DOll.10 and two cyclin  D3 transfectants  upon TCK stimulation. (F) Proliferation  of  DOll.10, a pMKITneo  vector transfectant 
(DOKIT-2), and a cyclin D3 transfectant (DOCyD3-3).  T cells were stimulated for 10 h and pulsed with [3H]thymidine for 1 h. The results were 
expressed as the mean  _+  SD of the triplicate culture. 
cyclin in various cell types, was  not  as strong  as  the cyclin 
D3-associated kinase activity in unstimulated cells. After stim- 
ulation, cdk4 kinase activity and cyclin D3-associated kinase 
activity were suppressed to 40 and <10%, respectively, cdk4 
protein in the complex with cyclin D3  changed in parallel 
with cyclin D3 protein, indicating that the complex forma- 
tion of cdk4  and  cyclin D3  was  not  affected by the  signal 
through TCR. These results suggest that cyclin D3 in T  cell 
hybridomas is associated not only with cdk4 but also with 
other kinase(s),  presumably including cdk6,  since cdk6 has 
recently been reported as an important partner of D-type cy- 
dins  in T  cells  (17).  It  is possible  that  the  signal  through 
TCR may affect the association of cyclin D3 and these kinases. 
cdk2 kinase activity was very strong in comparison with 
that of cyclin D3-associated kinase or cdk4. cdk2 kinase ac- 
tivity decreased to ,o40% of that of nonstimulated cells. In 
cyclin D3 transfectants, cdk2 kinase activity was elevated in 
stimulated cells, suggesting that cyclin D3-associated kinase 
activity controls cdk2  kinase  activity. 
Cyclin D2 has been shown to possess activities similar to 
those of cyclin D3,  such as the activation of cdk2 or cdk4 
in insect cells (21, 24), inhibition of pKb function to induce 
growth arrest in an osteosarcoma cell line (22-24), and inhi- 
bition of granulocyte differentiation (47).  In contrast  with 
cyclin D3, cyclin D2 mRNA and protein increased, although 
the kinase activity of the cyclin D2  complex was very low 
406  Cell Cycle Arrest Regulated by Cyclin D3 in T Cells and was not affected by TCR stimulation. Therefore, cyclin 
D3 but not D2 plays a crucial role in governing the transi- 
tion from G1  to S phase in T  cell hybridomas. 
Activation-induced growth arrest followed by ADCD has 
been found to be induced even in normal T cells when they 
are proliferating in the presence of IL-2 (3, 4). The question 
of whether the cell cycle arrest in normal T cells and cloned 
T cell lines upon Ag stimulation is induced by the same mech- 
anism as described here in T  cell hybridomas is important 
for  understanding  the  physiological regulation  of T  cell 
growth. Preliminary experiments indicated that the expres- 
sion patterns of G1 cyclins and cdk2 genes in a cloned T cell 
line proliferating in the presence oflb2 were almost the same 
as those in T  cell hybridomas when the G1 arrest was in- 
duced upon activation through TCR. Furthermore, the reduc- 
tion of cyclin D3 protein in the cloned T cell line after stim- 
ulation was more significant than in hybridomas (Miyatake, 
S., and T. Saito, unpublished observation). Therefore, we as- 
sume that, in normal T  cells, the activation signal through 
TCR blocks the growth-stimulatory signal through the 1I:2 
receptor mainly by suppressing the cyclin D3 expression and 
its associated  kinase activity. 
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